REGENERON PHARMACEUTICALS earnings per share and revenue

4REGN earnings per share for the last quarter are 11.66 EUR whereas the estimation was 10.90 EUR which accounts for 6.98% surprise. Company revenue for the same period amounts to 3.66 B EUR despite the estimated figure of 3.61 B EUR. Estimated earnings per share for the next quarter are 9.36 EUR, and revenue is expected to reach 3.31 B EUR. Also watch annual changes over time to get a bigger picture of 4REGN earnings per share and revenue dynamics.